| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.HYP.0000016179.52601.B4 |
| P698 | PubMed publication ID | 12019286 |
| P2093 | author name string | Noboru Fukuda | |
| Ryo Suzuki | |||
| Yukihiro Ikeda | |||
| Jin-Zi Su | |||
| Hitoshi Miyazaki | |||
| Katsuo Kanmatsuse | |||
| Yi-Mu Lai | |||
| Hiroto Takagi | |||
| Yoshiko Tahira | |||
| Xue-Qing Jin | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1021-1027 | |
| P577 | publication date | 2002-05-01 | |
| P1433 | published in | Hypertension | Q5958695 |
| P1476 | title | Angiotensin II type 2 receptor gene transfer downregulates angiotensin II type 1a receptor in vascular smooth muscle cells | |
| P478 | volume | 39 |
| Q62588793 | AGTR2 and sprint/power performance: a case-control replication study for rs11091046 polymorphism in two ethnicities |
| Q30434317 | ANG II type 2 receptor regulates smooth muscle growth and force generation in late fetal mouse development |
| Q41819451 | AT2 receptor-mediated vasodilation in the mouse heart depends on AT1A receptor activation |
| Q37274124 | AT2 receptors: functional relevance in cardiovascular disease. |
| Q37598488 | Adapter proteins and promoter regulation of the angiotensin AT2 receptor--implications for cardiac pathophysiology |
| Q35045801 | Angiotensin AT2 receptors: cardiovascular hope or hype? |
| Q36994675 | Angiotensin II AT(2) receptor decreases AT(1) receptor expression and function via nitric oxide/cGMP/Sp1 in renal proximal tubule cells from Wistar-Kyoto rats |
| Q35920857 | Angiotensin II Type 2 Receptor Decreases Transforming Growth Factor-β Type II Receptor Expression and Function in Human Renal Proximal Tubule Cells |
| Q39973660 | Angiotensin II bi-directionally regulates cyclooxygenase-2 expression in intestinal epithelial cells |
| Q36223169 | Angiotensin II receptor blockade and ventricular remodelling |
| Q36081206 | Angiotensin II type 2 receptor-mediated vasodilation. Focus on bradykinin, NO and endothelium-derived hyperpolarizing factor(s). |
| Q38275879 | Angiotensin type 1 and type 2 receptors during ontogeny: cardiovascular and renal effects |
| Q24324656 | Angiotensin type 2 receptor in resistance arteries of type 2 diabetic hypertensive patients |
| Q84356902 | Association of polymorphisms in angiotensin II receptor genes with aldosterone-producing adenoma |
| Q44855219 | Candesartan cilexetil protects cavernous tissue in spontaneously hypertensive rats |
| Q34557839 | Developmental changes in AT1 and AT2 receptor-protein expression in rats |
| Q46147302 | Effect of angiotensin type 2 receptor over-expression on the rat mesangial cell fibrotic phenotype: effect of gender |
| Q42171351 | Effects of dietary eritadenine on the liver microsomal Delta6-desaturase activity and its mRNA in rats |
| Q35672941 | HIV-associated nephropathy: role of AT2R. |
| Q54256113 | Hemodynamic effects of vasorelaxant compounds in mice lacking one, two or all three angiotensin II receptors. |
| Q33578073 | IL-8/CXCL8 Upregulates 12-Lipoxygenase Expression in Vascular Smooth Muscle Cells from Spontaneously Hypertensive Rats |
| Q36241932 | International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected]. |
| Q52937062 | Intronic ANG II type 2 receptor gene polymorphism 1675 G/A modulates receptor protein expression but not mRNA splicing. |
| Q35765146 | Is the angiotensin II Type 2 receptor cerebroprotective? |
| Q37921158 | LOX-1 and angiotensin receptors, and their interplay |
| Q35099106 | Local renin-angiotensin systems: the unanswered questions |
| Q44758286 | Mechanisms of angiotensin II-induced expression of B2 kinin receptors |
| Q37477602 | Molecular mechanisms of the antagonistic action between AT1 and AT2 receptors |
| Q37434021 | Oxidative stress in hypertension: role of the kidney |
| Q34075614 | Role of prolylcarboxypeptidase in angiotensin II type 2 receptor-mediated bradykinin release in mouse coronary artery endothelial cells |
| Q33217815 | The renin-angiotensin system: current data |
| Q39185363 | Transforming growth factor type beta 1 increases the expression of angiotensin II receptor type 2 by a SMAD- and p38 MAPK-dependent mechanism in skeletal muscle. |
| Q35686201 | Vascular angiotensin II actions mediated by angiotensin II type 2 receptors |
| Q47654610 | Venthamarai chooranam, a polyherbal Siddha medicine, alleviates hypertension via AT₁R and eNOS signaling pathway in 2K1C hypertensive rats. |
Search more.